MLSS MILESTONE SCIENTIFIC

Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call

Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call

ROSELAND, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 16th, 2024, to discuss the company’s financial results for the first quarter ended March 31, 2024, as well as the company’s corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or for international callers and by entering the access code: 525731. A webcast and replay of the call may be accessed at Webcast URL: .

An audio replay of the call will be available through May 30, 2024, and can be accessed by dialing 877-481-4010 for U.S. callers or for international callers and by entering the access code: 50619.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS), a technology-focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the or visit .

Contact:

Crescendo Communications, LLC

Email:

Tel: 212-671-1020



EN
13/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MILESTONE SCIENTIFIC

 PRESS RELEASE

Milestone Scientific Receives Regulatory Approval to Market CompuFlo® ...

Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back pain An estimated 4-5 million epidural anesthesia procedures are performed annually in Brazil; potential to expand this addressable market due to CompuFlo’s technological advantages ROSELAND, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announces...

 PRESS RELEASE

Milestone Scientific Reports Revenue of $2.2 Million and Provides Busi...

Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024 Sales through new online portal increase 31% over the same period last year Gross margin for the first quarter of 2024 increases to 74.5% from 72.7% for the same period last year Reports steady progress on reimbursement strategy for the CompuFlo® Epidural System ROSELAND, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a bu...

 PRESS RELEASE

Milestone Scientific Schedules First Quarter 2024 Financial Results an...

Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call ROSELAND, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 16th, 2024, to discuss the company’s financial results for the first quarter ended March 31, 2024, as well as the company’s corporate progress and other developments. The conference call will be avail...

 PRESS RELEASE

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables...

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida PRC Alliance Pain Relief Center operates 8 locations across central Florida Dr. Bakshi reports 100% success performing Epidural Steroid Injection (ESI) procedures during evaluation period ROSELAND, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of ® Epidural disposables into PRC Alliance Pain Reli...

 PRESS RELEASE

Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase...

Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023 Reports acceleration of reimbursement claims submission for the CompuFlo® Epidural System Technology ROSELAND, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and announces financial results for the year ending December 31, 2023. Arjan Haverhals, CEO and President of Milestone Scientific, stated, “We a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch